| For: | Li Y, Lee W, Zhao ZG, Liu Y, Cui H, Wang HY. Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma. World J Clin Oncol 2024; 15(1): 130-144 [PMID: 38292656 DOI: 10.5306/wjco.v15.i1.130] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i1/130.htm |
| Number | Citing Articles |
| 1 |
Long Wu, Guang-Ling Ou, Wei Zhang, Hua-Xing Ma, Xiao-Yun Li, Yun-Huan Zhen, Huan Wu, Kun Cao, Hai-Yang Li. Fatty acid-binding proteins in cancers. International Journal of Surgery 2025; 111(11): 8402 doi: 10.1097/JS9.0000000000003049
|
| 2 |
Christos Kakouratos, Adriana Fernandez Garcia, Pramod Darvin, Hemant M. Kocher. The Role of Intracellular Lipid-Binding Proteins in Digestive System Neoplasms. Current Oncology 2025; 32(10): 531 doi: 10.3390/curroncol32100531
|
| 3 |
Hongliang Liu, Zhenni Sun, Xi Wang, Bin Zhou, Lichao Cha. Identification of immunogenic cell death signature genes in hepatocellular carcinoma: from single-cell transcriptomics to in vitro mechanistic validation and comprehensive prognostic modeling with hundreds of machine learning algorithms. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1649618
|
| 4 |
Xiaofei Duan, Zhipin Yan, Jie Gao, Zhihui Wang, Bowen Hu, An Zhao, Lei Liu, Minghao Li, Jihua Shi, Wenzhi Guo, Shuijun Zhang. TMX1 promotes the progression of hepatocellular carcinoma by inhibiting ferroptosis via stabilizing FABP5. Cellular Signalling 2025; : 112349 doi: 10.1016/j.cellsig.2025.112349
|
